![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2008 The Author(s) Linking the functions of unrelated proteins using a novel directed evolution domain insertion method 1School of Biosciences and 2School of Chemistry, Cardiff University, Cardiff, UK *To whom correspondence should be addressed. Phone: +44 (0) 29 2087 4290, Fax: +44 (0) 29 2087 4116, Email: jonesdd/at/cf.ac.uk Present address: Kathy Busse, Institut für Biochemie der Med. Fakultät, Universität Leipzig, Leipzig, Germany Received April 11, 2008; Revised April 29, 2008; Accepted May 22, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract We have successfully developed a new directed evolution method for generating integral protein fusions comprising of one domain inserted within another. Creating two connections between the insert and accepting parent domain can result in the inter-dependence of the separate protein activities, thus providing a general strategy for constructing molecular switches. Using an engineered transposon termed MuDel, contiguous trinucleotide sequences were removed at random positions from the bla gene encoding TEM-1 β-lactamase. The deleted trinucleotide sequence was then replaced by a DNA cassette encoding cytochrome b562 with differing linking sequences at each terminus and sampling all three reading frames. The result was a variety of chimeric genes encoding novel integral fusion proteins that retained TEM-1 activity. While most of the tolerated insertions were observed in loops, several also occurred close to the termini of α-helices and β-strands. Several variants conferred a switching phenotype on Escherichia coli, with bacterial tolerance to ampicillin being dependent on the presence of haem in the growth medium. The magnitude of the switching phenotype ranged from 4- to 128-fold depending on the insertion position within TEM-1 and the linker sequences that join the two domains. INTRODUCTION Proteins consisting of multiple domains are commonly observed in nature and their domain arrangement is generally important for function (1). In most cases domain fusions are arranged tandemly in a ‘head-to-tail’ manner but 9% contain the insertion of one protein within another to produce integral fusion proteins (2). This results in the accepting or ‘parent’ domain being split by the ‘insert’ domain. Such an arrangement potentially allows communication between the separate domains by linked conformational changes, with the integral fusion protein thus acting as a molecular switch. A classic example in nature that illustrates this is the GroEL chaperone where an integral domain arrangement links the peptide binding and ATPase sites to allow the efficient folding of proteins (3). The ability to build tailored protein switches that change their properties in response to a desired input will allow significant new possibilities for creating novel sensors, modulators and transducers for use in both natural and artificial contexts (4–7). The construction of novel integral protein fusions comprised of normally disparate domains or proteins may provide a general approach for creating such switches (8,9). Although the generation of recombinant fusion proteins is common, they are usually constructed ‘end-to-end’ so that each domain acts autonomously. Insertion of one protein within another creates two shared links, so decreasing the degrees of freedom between the two domains and intimately linking their structures. This promotes communication between the functional centres so that one domain influences the structure and therefore activity of the other. The key to success of the domain insertion strategy is the identification of sites within a protein permissible to insertions of whole domains that also retains and links the functions of the individual domains. Such stringent criteria make predicting potential insertion sites difficult. There has been some success with rationally designed protein switches (10–12) but generally a number of different insertion positions were sampled (mostly within loops) and only modest switching magnitudes were observed. The construction of integral fusion proteins was therefore greatly aided by the development of combinatorial approaches to domain insertion that used DNaseI to introduce random breaks into a target DNA segment (13,14). However, it is notoriously difficult to generate single cuts in DNA using DNaseI and digestion with this nonspecific nuclease regularly produces tandem duplications and nested deletions of unpredictable sizes within the parent gene. This leads to frameshifts along with insertions and deletions of greatly varying lengths in the parent protein, so reducing library quality and increasing the number of variants that need to be sampled. A proposed transposon-based method (Figure 1
Here we show that our method can generate a range of chimeric genes encoding functional integral fusions with cyt b inserted at a variety of different positions within TEM-1. Many of these integral fusions proteins exhibited switching behaviour, with in vivo β-lactamase activity regulated positively or negatively in the presence of exogenous haem. MATERIALS AND METHODS Construction and digestion of the BLAΔ198 library The transposon insertion library (termed BLA 198) that contained 198 variants with MuDel inserted randomly within the bla gene was a subset of a previously generated library (16). Briefly, transposition was performed using MuA transposase (Finnzymes), MuDel and the bla gene resident within the plasmid pNOM as template [see (15) for details]. The transposition reaction products were used to transform E. coli DH5α by electroporation and the cells grown on LB agar containing 25 μg/ml chloramphenicol (Cam). The selection of clones with MuDel inserted within the bla gene of pNOM was performed using a positive selection for Cam resistance followed by a screen for ampicillin (Amp) sensitivity (15). Each of the selected colonies was transferred to 96 well culture plates (Nunc) containing LB and 25 μg/ml Cam and grown overnight at 37°C. A 50 μl aliquot of each culture was pooled and plasmid DNA isolated using the Qiagen HiSpeed plasmid midi kit. The plasmid pool was digested with MlyI (NE Biolabs) to remove MuDel (Figure 2
Construction and analysis of the domain insertion library The cybC cassettes constructed as outlined in Supplementary Methods using various combinations of oligonucleotide primers (Supplementary Tables 1 and 2) were ligated into the break in pNOM left by MuDel removal. Ligations were performed using the Quick T4 DNA Ligase kit (NE Biolabs) in a total volume of 20 μl containing 50 ng linear pNOM and 22.6 ng of a single cybC ORF cassette library (molar ratio of 1:3). The ligation products were used to transform E. coli DH5α cells by electroporation. Transformed cells were grown on LB agar supplemented with 25 μg/ml Amp at 37°C for at least 16 h. Amp-resistant colonies were screened by colony PCR using the GoTaq DNA polymerase (Promega) system and primers DDJdi010 and DDJdi011 (Supplementary Table 1). Clones deemed to have a cybC cassette inserted within bla were further analysed by colony PCR using primers DDJdi010 (vector-based) and WREcbr012 (cybC-based). Full-length PCR products generated using DDJdi010 and DDJdi011 were sequenced (DNA Sequencing Core, Molecular Biology Unit, Cardiff University). Analysis of the minimum inhibitory concentration (MIC) of Amp required to prevent cell growth was performed in 96-well flat-bottomed plates containing M9 minimal medium (24) supplemented with 0.001% w/v thiamine, 0.5% v/v glycerol, 0.1% w/v NaHCO3 and either 10 μM hemin (Fluka) or an equivalent volume of 0.5 M NaOH. Hemin was prepared fresh as a 10 mM stock solution in 0.5 M NaOH and filtered through a 0.45 μm filter to remove aggregated material. Amp was added to the medium as a two-fold serial dilution from 32 000 µg/ml to 8 µg/ml. The wells were filled and covered with an impermeable plate seal to prevent gaseous exchange. Cells were grown under oxygen starvation conditions for about 20–24 h at 37°C. Optical density (OD) was measured at 650 nm using a Molecular Devices Thermomax microplate reader. Cultures with an OD650 that was ≤5% of that in the absence of Amp were deemed to exhibit no growth. Western blot analysis of periplasmic expression levels of tested proteins was performed as outlined in Supplementary Methods. RESULTS Linking haem binding to β-lactamase activity Our rationale for constructing integral domain fusions that act as molecular switches is based on the concept of allostery (25). Natural allosteric proteins have distinct regions for activity and its regulation. Switching is achieved by binding of an effector molecule (typically a small molecule) to the regulation site, causing conformational changes that result in the direct modulation of protein activity. The architecture of integral domain fusion proteins should allow this process to be mimicked by creating an intimate link between two normally unrelated proteins to promote the transmission of conformational changes (Figure 1 Cyt b and TEM-1 were chosen to act as the regulation and reporter domains, respectively. Cyt b binds haem non-covalently close to its termini resulting in major conformational changes (Figure 1 Construction of domain insertion libraries Our directed evolution domain insertion approach was implemented as outlined in Figure 1 The nature of the DNA cassette encoding the insert domain is critical; two factors that need to be considered are linker sequence and coding frame. Short linkers may adversely affect the tolerance of the parent protein to a domain insertion, whereas long linkers may result in functional decoupling of the two domains. In this work, two types of linkers were incorporated into the cybC cassette encoding cyt b (Figure 2 Due to the nature of transposon insertion, the single break can occur at three different positions with respect to a single codon (15). The use of only one open reading frame (ORF) for the cybC cassette would make 2/3 of the library unproductive due to frameshifts, so reducing the potential diversity of insertion positions sampled. Therefore, two further versions of the cybC cassette were constructed with both termini modified to compensate for any potential frameshifts (Figure 2 A total of six separate libraries of cybC inserts were constructed to represent the different linker sequences and ORFs: cybC-GGS-1 to 3 comprised the different tripeptide linker combinations in each reading frame and cybC-X-1 to 3 contained the randomized single amino acid linker combinations, also in each reading frame. A previously constructed library of 198 bla gene variants with MuDel inserted at different positions (16), termed BLA 198, was used as the starting point. MuDel was removed from the plasmid pool representing the 198 variants and each cybC cassette library was ligated individually into the different break points in bla, followed by transformation of E. coli. Cell growth on LB agar supplemented with 25 μg/ml Amp was used to select clones containing modified bla genes encoding active TEM-1.Tolerance of TEM-1 to insertion of cyt b A total of 70 colonies derived from the cybC-GGS libraries and 42 colonies derived from the cybC-X libraries were arbitrarily chosen and screened by PCR to identify chimeric bla genes with in-frame cybC insertions. We found 42 of the cybC-GGS derived clones and 12 of the cybC-X derived clones to contain an insert within bla (data not shown). Of these, two appeared to contain two cybC cassettes inserted within bla. The colonies that did not contain an insert generated PCR products close to the size expected for wild-type bla (data not shown), probably due to recircularization of the host plasmid. Reconstitution of the bla gene with a trinucleotide segment removed can give rise to false positives, as TEM-1 can tolerate deletion of an amino acid at various positions (16). Considering that intramolecular ligation of plasmid DNA is far more efficient than intermolecular ligation, our efforts to minimize recircularization by dephosphorylation were largely successful as 48% of the colonies contained a chimeric bla-cybC gene. The drop in frequency of positive clones derived from the cybC-X libraries could be a consequence of decreased tolerance of TEM-1 to the insertion of cyt b with shorter linkers. An indication of the distribution of tolerated insertion positions within bla was obtained by PCR using one primer that annealed 58 bp upstream of bla and a second that bound to the 3′ end of the cybC insert. Depending on the insertion position within bla, the expected PCR fragment size would range from ca 380 bp (insertion at 5′ end of bla) to ca 1250 bp (insertion at 3′ end of bla). The size distribution of the various fragments indicated the insertion of cybC occurred throughout bla (Supplementary Figure 1). To confirm both the exact insertion position and nature of any required linker sequence, 20 variants derived from the cybC-GGS libraries and all 12 variants derived from the cybC-X libraries were sequenced (Supplementary Table 3). Eighteen different insertion positions distributed throughout bla were observed (Figure 3
Sixteen distinct positions within the primary structure of TEM-1 were found to tolerate insertion of cyt b (Table 1). The tolerated insertion positions were found throughout the protein, but with a higher proportion in the C-terminal half of the protein. Mapping the insertion positions onto the tertiary structure of TEM-1 revealed that most occurred in loops, or close to the terminus of a helix or β-strand (Figure 4
Analysis of the linker regions indicated that most of the variants required at least one linker (Table 1). Five variants (Tc-03, Tc-06, Tc-13, Tc-16 and Tc-18) had no linker, which included both variants with the insertion of two tandem cyt b domains (Tc-06 and Tc-13). Analysis of variants derived from the cybC-X-series of libraries showed that glycine was the most common residue (5 times as an N-terminal linker and once as a C-terminal linker). Most amino acids that comprised the linker were small and/or polar residues, but hydrophobic residues such as valine, isoleucine and leucine were also observed. It must be noted that the length (by one residue) and sequence of the linker can vary in order to accommodate the frame compensation versions of the cybC insert (ORFs II and III in Figure 2 Influence of cyt b insertion on TEM-1 activity Insertion of cyt b would normally be considered a major and sometimes detrimental influence on TEM-1 structure and hence activity. This in turn will influence the MIC of Amp that prevents E. coli growth. Furthermore, if the integral fusion protein displays switching properties, the presence of haem in the growth media will also affect the degree of bacterial resistance to Amp. To estimate activity of the various chimeric proteins in vivo, the Amp MIC required to inhibit E. coli growth both in the absence and presence of haem was measured. Cells containing the original starting vector that contains wild-type bla (pNOM) or a vector expressing separate wild-type bla and cybC genes (pPB10 (30)) or no vector were used as controls. Many of the clones exhibited resistance to Amp that was only slightly compromised relative to cells producing wild-type TEM-1 via pNOM-borne bla (Table 1). Half of the 32 analysed clones conferred an Amp MIC value on E. coli of 16 000 μg/ml or greater. Variants that contained cyt b insertions at similar positions in most cases conferred a similar Amp MIC. Differences in linkers or the presence of tandem cyt b inserts could account for the slight variation in Amp MIC values (e.g. compare variants with insertions that replace Asp115 of TEM-1). Insertions within the TEM-1 signal sequence that replace Arg7 did not totally abolish protein export but must have affected the level of active enzyme in the periplasm as these variants conferred an Amp MIC of ≤8000 μg/ml (Table 1). Several variants with cyt b insertions positioned close to the active site still retained significant β-lactamase activity, although this was generally much lower than that of cells expressing wild-type TEM-1. For example, while TEM-1 tolerated an insertion between residues Ile173-Asn175 (Tc-09) and Asn170-Ala172 (Tc-15) in the catalytically important Ω-loop, the activity of these variants was considerably compromised compared to wild-type TEM-1 (Table 1). Eleven of the 32 analysed integral fusion variants exhibited significant haem-dependent β-lactamase activity (>2-fold change in MIC value in the presence of 10 μM haem). The change in Amp MIC values varied from a 4-fold increase to a 128-fold decrease when haem was present in the culture medium (Table 1). Variants that displayed negative modulation of TEM-1 activity were predominant. The only variant conferring positive modulation (Tc-06) had a tandem cyt b insertion that replaced Asp115 in TEM-1 (Table 1). The largest haem-dependent decreases in TEM-1 activity were observed for variants with cyt b insertions between Glu212 and Glu215 (Figure 4 Integral fusion protein levels in the periplasm Western blotting was used to assess the level of cyt b-TEM-1 chimeras exported to the periplasm for several clones exhibiting a switching phenotype, to confirm that any change in Amp MIC values was not due to a correlated change in the level of the full-length integral fusion protein. Each of the fusion proteins was detected as a single band on the Western blot, migrating with an apparent molecular weight of ca 42–43 kDa, close to that predicted. For three of the fusion proteins (Tc-22, Tc-29 and Tc-31) the intensity of the bands was similar for cells grown in the presence and absence of haem, suggesting that the level of the fusion protein in the periplasmic fraction was unaffected by the presence of haem (Figure 5
DISCUSSION While the insertion of a domain could be considered as a destructive modification to the accepting protein due to disruption of its original polypeptide chain continuity, it also provides a means for constructing novel proteins that integrate and therefore couple normally unrelated functions (7–9). However, the challenge lies not only in identifying suitable positions within the parent domain that permit a domain insertion, but also in finding those that allow communication between the functional centres of the individual domains. Here we have shown that our transposon-based method provides a useful alternative to DNaseI-based methods for generating libraries of novel active integral fusion proteins by the replacement of an amino acid in the TEM-1 parent domain with the cyt b insert. Reading frame compensation and the ability to define the nature of domain linkers expanded the degree of useful diversity generated and sampled, leading to the discovery of integral fusion proteins displaying apparent switching properties. TEM-1 was found to tolerate the insertion of cyt b at a variety of positions spread throughout the protein (Figures 3 The very nature of the structural link between the two domains in an integral fusion protein would suggest that in some instances their individual functions would be linked. Haem regulation of TEM-1 was observed for several of the variants, with their in vivo activity towards Amp varying depending on the presence of haem in the growth medium (Table 1). Both positive and negative regulation of β-lactamase activity by haem was observed. The observed switching phenotypes displayed a wide range of magnitudes, which depended on both the position of cyt b insertion within TEM-1 and the linker sequence connecting the domains. For some variants, analysis of the insertion point within the context of TEM-1 tertiary structure provided a rationale for the switching properties. Cyt b insertions that replaced Asp214 or residues in the Thr266 to Glu274 region conferred a switching phenotype. These residues lie close to the active site pocket and are situated at the sub-domain interface of TEM-1 (Figure 4 The linker sequence that joins TEM-1 and cyt b appeared to be critical in defining the switching magnitude of the integral fusion protein. For example, the switching magnitude of variants with cyt b replacing Asp214 varied between 32- and 128-fold depending on the nature of the linker sequence. It was apparent that shorter linkers promoted switching properties. Only one variant (Tc-01) with the extended tripeptide linker at both domain connection points exhibited switching behaviour. All the other switching variants contained short or no linkers. As the majority of variants conferring a switching phenotype displayed negative modulation of TEM-1 activity in the presence of haem, this would suggest that in the present context haem-activated variants would be difficult to construct. One variant, Tc-06, did exhibit a 4-fold positive modulation of β-lactamase activity in the presence of haem (Table 1). This variant is unusual as it contains two tandem cyt b insertions that replace Asp115, with a flexible GGPGGS linker joining the cyt b domains. The lack of switching behaviour for Tc-13 that also contains a tandem insertion of two cyt b but replacing Gly116 (Table 1) could be due to the slight difference in insertion position or the lack of linker that joins the two cyt b units. Tc-13 was also less active in vivo than Tc-06 suggesting that this double cyt b insertion was more disruptive to TEM-1. A number of other reports have identified integral fusion proteins that exhibit switching behaviour in response to ligand binding (10,12–14,35). Most had activities that differed by up to 2- to 8-fold in the presence of their respective ligands. The most successful example thus far was produced by a combinatorial approach using a circular permuted version of TEM-1 as the reporter domain, and a 600-fold difference in activity was reported on analysis in vitro (23). This same variant exhibited only a 16-fold change in Amp MIC in the presence and absence of ligand in an in vivo assay. Using an in vivo assay based on the same principles, we identified cyt b-TEM-1 variants from a relatively small starting library size with the magnitude of the haem-dependent switching phenotype ranging between 32- and 128-fold. A more complete analysis of these particular variants in vitro will reveal the true extent of their switching magnitude independent of any potential in vivo effects, the influence of redox conditions on switching and any structural changes on haem binding responsible for regulating β-lactamase activity. This work is currently underway. In conclusion, we have demonstrated that our transposon-based directed evolution domain insertion method can generate a diverse range of novel integral fusion proteins. Our method combines the ability of rational protein engineering to replace one amino acid with a new insert domain having predefined linkers, with the power of directed evolution to sample many different insertion positions. This method can easily be scaled up to sample many more different insertion positions in TEM-1, and can also be expanded to construct integral fusion proteins that link together a variety of different and normally unrelated proteins to construct novel protein switches. SUPPLEMENTARY DATA Supplementary Data are available at NAR Online. [Supplementary Data]
ACKNOWLEDGEMENTS This work was supported by the Biotechnology and Biological Sciences Research Council (BB/E007384 and BB/E001084) and the Welsh Assembly Government (HE07POC3007). We would like to thank Dr Paul Barker, University of Cambridge, for supplying pPB10. Funding to pay the Open Access publication charges for this article were waived. Conflict of interest statement. None declared. REFERENCES 1. Bornberg-Bauer E, Beaussart F, Kummerfeld SK, Teichmann SA, Weiner J., III The evolution of domain arrangements in proteins and interaction networks. Cell. Mol. Life Sci. 2005;62:435–445. [PubMed] 2. Aroul-Selvam R, Hubbard T, Sasidharan R. Domain insertions in protein structures. J. Mol. Biol. 2004;338:633–641. [PubMed] 3. Sigler PB, Xu Z, Rye HS, Burston SG, Fenton WA, Horwich AL. Structure and function in GroEL-mediated protein folding. Annu. Rev. Biochem. 1998;67:581–608. [PubMed] 4. Ambroggio XI, Kuhlman B. Design of protein conformational switches. Curr. Opin. Struct. Biol. 2006;16:525–530. [PubMed] 5. Buskirk AR, Liu DR. Creating small-molecule-dependent switches to modulate biological functions. Chem. Biol. 2005;12:151–161. [PubMed] 6. Lim WA. The modular logic of signaling proteins: building allosteric switches from simple binding domains. Curr. Opin. Struct. Biol. 2002;12:61–68. [PubMed] 7. Villaverde A. Allosteric enzymes as biosensors for molecular diagnosis. FEBS Lett. 2003;554:169–172. [PubMed] 8. Ferraz RM, Vera A, Aris A, Villaverde A. Insertional protein engineering for analytical molecular sensing. Microbial Cell Factories. 2006;5:15. [PubMed] 9. Ostermeier M. Engineering allosteric protein switches by domain insertion. Protein Eng. Des. Sel. 2005;18:359–364. [PubMed] 10. Baird GS, Zacharias DA, Tsien RY. Circular permutation and receptor insertion within green fluorescent proteins. Proc. Natl Acad. Sci. USA. 1999;96:11241–11246. [PubMed] 11. Betton JM, Jacob JP, Hofnung M, Broome-Smith JK. Creating a bifunctional protein by insertion of β-lactamase into the maltodextrin-binding protein. Nat. Biotechnol. 1997;15:1276–1279. [PubMed] 12. Collinet B, Herve M, Pecorari F, Minard P, Eder O, Desmadril M. Functionally accepted insertions of proteins within protein domains. J. Biol. Chem. 2000;275:17428–17433. [PubMed] 13. Biondi RM, Baehler PJ, Reymond CD, Veron M. Random insertion of GFP into the cAMP-dependent protein kinase regulatory subunit from Dictyostelium discoideum. Nucleic Acids Res. 1998;26:4946–4952. [PubMed] 14. Guntas G, Mitchell SF, Ostermeier M. A molecular switch created by in vitro recombination of nonhomologous genes. Chem. Biol. 2004;11:1483–1487. [PubMed] 15. Jones DD. Triplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 β-lactamase to an amino acid deletion. Nucleic Acids Res. 2005;33:e80. [PubMed] 16. Simm AM, Baldwin AJ, Busse K, Jones DD. Investigating protein structural plasticity by surveying the consequence of an amino acid deletion from TEM-1 β-lactamase. FEBS Lett. 2007;581:3904–3908. [PubMed] 17. Arnesano F, Banci L, Bertini I, Faraone-Mennella J, Rosato A, Barker PD, Fersht AR. The solution structure of oxidized Escherichia coli cytochrome b562. Biochemistry. 1999;38:8657–8670. [PubMed] 18. Feng Y, Sligar SG, Wand AJ. Solution structure of apo-cytochrome b562. Nat. Struct. Biol. 1994;1:30–35. [PubMed] 19. Jones DD, Barker PD. Design and characterisation of an artificial DNA-binding cytochrome. Chembiochem. 2004;5:964–971. [PubMed] 20. Jones DD, Barker PD. Controlling self-assembly by linking protein folding, DNA binding, and the redox chemistry of Heme. Angew. Chem. Int. Ed. Engl. 2005;44:6337–6341. [PubMed] 21. Matagne A, Lamotte-Brasseur J, Frere JM. Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem. J. 1998;330:581–598. [PubMed] 22. Guntas G, Ostermeier M. Creation of an allosteric enzyme by domain insertion. J. Mol. Biol. 2004;336:263–273. [PubMed] 23. Guntas G, Mansell TJ, Kim JR, Ostermeier M. Directed evolution of protein switches and their application to the creation of ligand-binding proteins. Proc. Natl Acad. Sci. USA. 2005;102:11224–11229. [PubMed] 24. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory; 1982. 25. Changeux JP, Edelstein SJ. Allosteric mechanisms of signal transduction. Science. 2005;308:1424–1428. [PubMed] 26. Krishna MM, Englander SW. The N-terminal to C-terminal motif in protein folding and function. Proc. Natl Acad. Sci. USA. 2005;102:1053–1058. [PubMed] 27. D’Amelio N, Bonvin AM, Czisch M, Barker P, Kaptein R. The C terminus of apo-cytochrome b562 undergoes fast motions and slow exchange among ordered conformations resembling the folded state. Biochemistry. 2002;41:5505–5514. [PubMed] 28. Haapa S, Taira S, Heikkinen E, Savilahti H. An efficient and accurate integration of mini-Mu transposons in vitro: a general methodology for functional genetic analysis and molecular biology applications. Nucleic Acids Res. 1999;27:2777–2784. [PubMed] 29. Galarneau A, Primeau M, Trudeau LE, Michnick SW. β-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat. Biotechnol. 2002;20:619–622. [PubMed] 30. Barker PD, Nerou EP, Freund SM, Fearnley IM. Conversion of cytochrome b562 to c-type cytochromes. Biochemistry. 1995;34:15191–15203. [PubMed] 31. Hallet B, Sherratt DJ, Hayes F. Pentapeptide scanning mutagenesis: random insertion of a variable five amino acid cassette in a target protein. Nucleic Acids Res. 1997;25:1866–1867. [PubMed] 32. Hayes F, Hallet B, Cao Y. Insertion mutagenesis as a tool in the modification of protein function. Extended substrate specificity conferred by pentapeptide insertions in the omega-loop of TEM-1 β-lactamase. J. Biol. Chem. 1997;272:28833–28836. [PubMed] 33. Legendre D, Soumillion P, Fastrez J. Engineering a regulatable enzyme for homogeneous immunoassays. Nat. Biotechnol. 1999;17:67–72. [PubMed] 34. Baldwin AJ, Busse K, Simm AJ, Jones D. Expanded molecular diversity generation during directed evolution by trinucleotide exchange (TriNEx). Nucleic Acids Res. 2008 doi:10..1093/nar/GKN358. 35. Doi N, Yanagawa H. Insertional gene fusion technology. FEBS Lett. 1999;457:1–4. [PubMed] 36. Jelsch C, Mourey L, Masson JM, Samama JP. Crystal structure of Escherichia coli TEM-1 β-lactamase at 1.8 A resolution. Proteins. 1993;16:364–383. [PubMed] 37. Ambler RP, Coulson AF, Frere JM, Ghuysen JM, Joris B, Forsman M, Levesque RC, Tiraby G, Waley SG. A standard numbering scheme for the class A β-lactamases. Biochem. J. 1991;276:269–270. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Cell Mol Life Sci. 2005 Feb; 62(4):435-45.
[Cell Mol Life Sci. 2005]J Mol Biol. 2004 May 7; 338(4):633-41.
[J Mol Biol. 2004]Annu Rev Biochem. 1998; 67():581-608.
[Annu Rev Biochem. 1998]Curr Opin Struct Biol. 2006 Aug; 16(4):525-30.
[Curr Opin Struct Biol. 2006]Chem Biol. 2005 Feb; 12(2):151-61.
[Chem Biol. 2005]Curr Opin Struct Biol. 2002 Feb; 12(1):61-8.
[Curr Opin Struct Biol. 2002]FEBS Lett. 2003 Nov 6; 554(1-2):169-72.
[FEBS Lett. 2003]Microb Cell Fact. 2006 Apr 3; 5():15.
[Microb Cell Fact. 2006]Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11241-6.
[Proc Natl Acad Sci U S A. 1999]Nat Biotechnol. 1997 Nov; 15(12):1276-9.
[Nat Biotechnol. 1997]J Biol Chem. 2000 Jun 9; 275(23):17428-33.
[J Biol Chem. 2000]Nucleic Acids Res. 1998 Nov 1; 26(21):4946-52.
[Nucleic Acids Res. 1998]Chem Biol. 2004 Nov; 11(11):1483-7.
[Chem Biol. 2004]Nucleic Acids Res. 2005 May 16; 33(9):e80.
[Nucleic Acids Res. 2005]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]Biochemistry. 1999 Jul 6; 38(27):8657-70.
[Biochemistry. 1999]Nat Struct Biol. 1994 Jan; 1(1):30-5.
[Nat Struct Biol. 1994]Chembiochem. 2004 Jul 5; 5(7):964-71.
[Chembiochem. 2004]Nat Struct Biol. 1994 Jan; 1(1):30-5.
[Nat Struct Biol. 1994]Biochemistry. 1999 Jul 6; 38(27):8657-70.
[Biochemistry. 1999]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]Nucleic Acids Res. 2005 May 16; 33(9):e80.
[Nucleic Acids Res. 2005]Science. 2005 Jun 3; 308(5727):1424-8.
[Science. 2005]Proc Natl Acad Sci U S A. 2005 Jan 25; 102(4):1053-8.
[Proc Natl Acad Sci U S A. 2005]Biochemistry. 1999 Jul 6; 38(27):8657-70.
[Biochemistry. 1999]Biochemistry. 2002 Apr 30; 41(17):5505-14.
[Biochemistry. 2002]Nucleic Acids Res. 1999 Jul 1; 27(13):2777-84.
[Nucleic Acids Res. 1999]Nucleic Acids Res. 2005 May 16; 33(9):e80.
[Nucleic Acids Res. 2005]Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11241-6.
[Proc Natl Acad Sci U S A. 1999]Proc Natl Acad Sci U S A. 2005 Aug 9; 102(32):11224-9.
[Proc Natl Acad Sci U S A. 2005]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]Biochemistry. 1999 Jul 6; 38(27):8657-70.
[Biochemistry. 1999]Biochemistry. 2002 Apr 30; 41(17):5505-14.
[Biochemistry. 2002]Nucleic Acids Res. 2005 May 16; 33(9):e80.
[Nucleic Acids Res. 2005]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]Biochem J. 1991 May 15; 276 ( Pt 1)():269-70.
[Biochem J. 1991]Proteins. 1993 Aug; 16(4):364-83.
[Proteins. 1993]Biochem J. 1991 May 15; 276 ( Pt 1)():269-70.
[Biochem J. 1991]Proteins. 1993 Aug; 16(4):364-83.
[Proteins. 1993]Biochem J. 1998 Mar 1; 330 ( Pt 2)():581-98.
[Biochem J. 1998]Nat Biotechnol. 2002 Jun; 20(6):619-22.
[Nat Biotechnol. 2002]Proteins. 1993 Aug; 16(4):364-83.
[Proteins. 1993]Proteins. 1993 Aug; 16(4):364-83.
[Proteins. 1993]Biochemistry. 1995 Nov 21; 34(46):15191-203.
[Biochemistry. 1995]FEBS Lett. 2003 Nov 6; 554(1-2):169-72.
[FEBS Lett. 2003]Microb Cell Fact. 2006 Apr 3; 5():15.
[Microb Cell Fact. 2006]Protein Eng Des Sel. 2005 Aug; 18(8):359-64.
[Protein Eng Des Sel. 2005]Nucleic Acids Res. 1997 May 1; 25(9):1866-7.
[Nucleic Acids Res. 1997]J Biol Chem. 1997 Nov 14; 272(46):28833-6.
[J Biol Chem. 1997]Nat Biotechnol. 1999 Jan; 17(1):67-72.
[Nat Biotechnol. 1999]FEBS Lett. 2007 Aug 21; 581(21):3904-8.
[FEBS Lett. 2007]Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11241-6.
[Proc Natl Acad Sci U S A. 1999]J Biol Chem. 2000 Jun 9; 275(23):17428-33.
[J Biol Chem. 2000]Nucleic Acids Res. 1998 Nov 1; 26(21):4946-52.
[Nucleic Acids Res. 1998]Chem Biol. 2004 Nov; 11(11):1483-7.
[Chem Biol. 2004]FEBS Lett. 1999 Aug 20; 457(1):1-4.
[FEBS Lett. 1999]